Table 1 Clinicopathological characteristics of patients with LUAD from TCGA-LUAD database
From: Hsa-miR-21 promoted the progression of lung adenocarcinoma by regulating LRIG1 expression
Characteristics | Patients(N = 501) | ||
|---|---|---|---|
NO. | % | ||
Gender | Female | 271 | 54.09% |
Male | 230 | 45.91% | |
Age | ≤ 66(Median) | 259 | 51.70% |
> 66(Median) | 242 | 48.30% | |
Grade | I | 269 | 53.69% |
II | 119 | 23.75% | |
III | 80 | 15.97% | |
IV | 25 | 4.99% | |
Unknown | 8 | 1.60% | |
Survival Time | Long(> 5 years) | 251 | 50.10% |
Short(< 5 years) | 52 | 10.38% | |
OS status | Dead | 182 | 36.33% |
Alive | 319 | 63.67% | |
Radiation | Yes | 416 | 83.03% |
No | 71 | 14.17% | |
Unknown | 14 | 2.79% | |
Tobacco | Yes | 58 | 11.58% |
No | 361 | 72.06% | |
Unknown | 82 | 16.37% | |